Breakthrough in Breast Cancer Treatment: Global Study Results Offer Hope for Early-Stage Patients

17 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
New Zealand's breast cancer rates are among the highest globally, with a significant impact on women's health. However, a recent international study has revealed a major advancement in early breast cancer treatment. The study found that ribociclib (Kisqali) can significantly reduce the risk of recurrence in women with early-stage breast cancer (stages II and III). This treatment, already publicly funded for advanced cases, is now under assessment for expanded access. With around 900 high-risk early-stage patients expected to benefit, advocates are calling for faster access to this potentially life-saving therapy. Join us as we delve into the details of this groundbreaking study and its potential impact on breast cancer treatment.
Categoria
Oncology
Commenta per primo questo video.

Prossimo